Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Cingulate Inc (CING)

Cingulate Inc (CING)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cingulate Inc. To Present at the LD Micro Main Event XVI Newsfile - Thu Sep 21, 2023

Presentation on Wednesday, October 4th at 02:30 PM PTKansas City, Kansas--(Newsfile Corp. - September 21, 2023) - Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision...

CING : 0.9646 (-13.87%)
Wall Street - shutterstock_1321462400
Stocks Set to Open Lower as Bank Shares Fall Barchart - Mon Mar 13, 2023

March S&P 500 futures ( ESH23 ) are down -1.2%, and March Nasdaq 100 E-Mini futures ( NQH23 ) are down -0.91% this morning as investors weighed the emergency measures presented by the U.S. financial authorities...

ESH23 : 3,957.05s (-0.09%)
NQM24 : 18,000.75s (+1.99%)
NKLA : 0.6575 (+7.35%)
MRK : 127.51 (-0.58%)
TFC : 38.85 (+1.30%)
CING : 0.9646 (-13.87%)
BTI : 29.81 (+0.03%)
FRC : 3.51 (-43.30%)
WAL : 61.29 (+2.22%)
Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update Globe Newswire - Thu Aug 11, 2022

$5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc....

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)
Kansas City Business Journal Names Cingulate’s Louis G. Van Horn a 2022 Chief Financial Officer of the Year Globe Newswire - Mon Jul 25, 2022

KC Business Veteran, Two-Time Award Winner, Helped Lead Cingulate to 2021 IPO...

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)
Cingulate Announces Completion of CTx-2103 Human Formulation Study for the Treatment of Anxiety Disorders Globe Newswire - Thu Jun 23, 2022

CTx-2103 (buspirone) is the Third Candidate Using Cingulate’s Proprietary Precision Timed Release™ Drug Delivery Platform Technology for Once-daily Dosing...

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)
Cingulate to Present at Diamond Equity Research 2022 Virtual Emerging Growth Invitational Globe Newswire - Fri Jun 17, 2022

KANSAS CITY, Kan., June 17, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)
Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event Globe Newswire - Thu Jun 2, 2022

KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)
Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders Globe Newswire - Tue May 24, 2022

Active Pharmaceutical Ingredient – Buspirone – One of the Most Widely Prescribed Agents in $5.5B U.S. Anxiety Market, Which Must be Taken Multiple Times...

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)
Cingulate to Present at H.C. Wainwright Global Investment Conference Globe Newswire - Wed May 18, 2022

KANSAS CITY, Kan., May 18, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)
Cingulate Inc. Reports First Quarter 2022 Results and Provides Clinical and Business Update Globe Newswire - Thu May 12, 2022

Announcement of First Dosage for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ Platform (PTR™) ...

CINGW : 0.0218 (-0.91%)
CING : 0.9646 (-13.87%)

Barchart Exclusives

2 Small-Cap Stocks With 40% to 60% Upside Barchart - Sat May 4, 2:45PM CDT
Wall Street believes these two growth stocks will soar, driven by the demand for their products. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot